United Kingdom· GB-APID-28420711000001107

Vamju 30mg modified-release tablets

A gliclazide product containing gliclazide, registered in United Kingdom by Advanz Pharma. The same ATC class is registered in 14 of our 19 countries.

ATC A10BB09

Checked against NHS dm+d (United Kingdom) on September 13, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about gliclazideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Gliclazide is registered in 14 of 19 countries.

Countries holding a registration under ATC A10BB09 (gliclazide), each read from that country’s own register.

This record: United Kingdom, from NHS dm+d (United Kingdom)
7 of them publish a price we can compare per daily dose

Search gliclazide products by name

Gliclazide · ATC A10BB09

14 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Polandprice
Switzerlandprice
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of gliclazide costs, country by country.

Normalised to the WHO defined daily dose (60 mg), the median price runs from $0.11 in France to $0.61 in Switzerland — a ×5.5 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Gliclazide · price per daily dose (60 mg)

USD · FX 28 Sept 2026

CH Switzerland$0.61
IT Italy$0.26
FR France$0.11

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)

Active substance: Gliclazide
Manufacturer: Advanz Pharma
Country: United Kingdom (GB)
ATC code: A10BB09
ATC class: Gliclazide
Defined daily dose: 60 mg, O
Reimbursed: Not published by this register
Source register: NHS dm+d (United Kingdom)
Last checked: September 13, 2026

Packs & prices · 2

gtin
5021691032724
gtin
5021691032731

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

5 interactions on record for gliclazide.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check gliclazide against other medicines How interaction checks work

Gliclazide · interactions on record

5 records

5 more interactions with mechanism and management, from a commercially licensed source.

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Gliclazide in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All gliclazide products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Diamicron Mr, Gliclada
Belgium · Gliclazide Sandoz, Uni Diamicron
Bulgaria · Гликлада, Диаб
Cyprus · Diamicron, Glicron
Czechia · Diaprel Mr, Gliclazid Viatris
Germany · Diamicron Uno, Glibemat
Denmark · Diamicron Uno, Gliclazid Krka
Estonia · Diaprel, Diaprel Mr
Spain · Diamicron, Gliclazida Aurovitas
France · Diamicron, Diamicron 60 Mg
Greece · Diamicron, Diamicron Mr
Croatia · Diaprel Mr, Gliclada
Hungary · Diaprel Mr, Gliclada
Ireland · Diaclide Mr, Diacronal Mr
Iceland · Diamicron Uno, Gliclatim
Italy · Diamicron, Dramion
Lithuania · Diaprel Mr, Gliclada
Luxembourg · Diamicron, Uni Gliclazide Eg
Latvia · Diaprel Mr, Gliclada
Malta · Diamicron, Gliclazide Bp Accord Healthcare
Netherlands · Diamicron Mr, Gliclazide Aurobindo
Poland · Clazicon, Diabrezide
Portugal · Diamicron Lm, Gliclazida Alter
Romania · Diaprel Mr, Gliclazide Gemax Pharma
Slovenia · Diaprel, Diaprel Mr
Slovakia · Diaprel Mr, Gliclada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f8c47fa0-6ed1-4ee2-a6b6-466eb3df97fa
GET /v1/drugs/f8c47fa0-6ed1-4ee2-a6b6-466eb3df97fa?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "28420711000001107",
  "desc": "Vamju 30mg modified-release tablets (Advanz Pharma)",
  "form": "Modified-release tablet",
  "vpid": "38896211000001104",
  "source": "dmd",
  "vtm_id": "776108001",
  "strength": "30 mg",
  "substance": "Gliclazide",
  "ingredient": "Gliclazide",
  "supplier_code": "24129411000001106"
}

API reference MCP server Plans

See everything about gliclazide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console